AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Cash From Investing

Annual CFI:

$75.65M-$16.40M(-17.81%)
December 31, 2024

Summary

  • As of today, AMLX annual cash from investing is $75.65 million, with the most recent change of -$16.40 million (-17.81%) on December 31, 2024.
  • During the last 3 years, AMLX annual cash from investing has risen by +$122.06 million (+263.03%).
  • AMLX annual cash from investing is now -17.81% below its all-time high of $92.05 million, reached on December 31, 2023.

Performance

AMLX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXcash flow metrics

Quarterly CFI:

$22.99M+$66.65M(+152.67%)
June 1, 2025

Summary

  • As of today, AMLX quarterly cash from investing is $22.99 million, with the most recent change of +$66.65 million (+152.67%) on June 1, 2025.
  • Over the past year, AMLX quarterly cash from investing has increased by +$51.95 million (+179.40%).
  • AMLX quarterly cash from investing is now -81.34% below its all-time high of $123.22 million, reached on June 30, 2023.

Performance

AMLX Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXcash flow metrics

TTM CFI:

$83.13M+$51.95M(+166.65%)
June 1, 2025

Summary

  • As of today, AMLX TTM cash from investing is $83.13 million, with the most recent change of +$51.95 million (+166.65%) on June 1, 2025.
  • Over the past year, AMLX TTM cash from investing has increased by +$198.44 million (+172.10%).
  • AMLX TTM cash from investing is now -9.69% below its all-time high of $92.05 million, reached on December 31, 2023.

Performance

AMLX TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AMLX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-17.8%+179.4%+172.1%
3Y3 Years+263.0%+415.3%+187.7%
5Y5 Years+100.0%--

AMLX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-17.8%+131.7%-81.3%+110.1%-9.7%+134.8%
5Y5-Year-17.8%+131.7%-81.3%+110.1%-9.7%+134.8%
All-TimeAll-Time-17.8%+131.7%-81.3%+110.1%-9.7%+134.8%

AMLX Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$22.99M(+152.7%)
$83.13M(+166.7%)
Mar 2025
-
-$43.66M(-167.2%)
$31.18M(-58.8%)
Dec 2024
$75.65M(-17.8%)
$64.98M(+67.4%)
$75.65M(+139.4%)
Sep 2024
-
$38.82M(+234.0%)
$31.60M(+127.4%)
Jun 2024
-
-$28.96M(-3636.1%)
-$115.31M(-412.7%)
Mar 2024
-
$819.00K(-96.1%)
$36.88M(-59.9%)
Dec 2023
$92.05M
$20.93M(+119.4%)
$92.05M(+158.6%)
Sep 2023
-
-$108.09M(-187.7%)
-$157.05M(-547.7%)
Jun 2023
-
$123.22M(+120.1%)
$35.08M(+141.9%)
DateAnnualQuarterlyTTM
Mar 2023
-
$55.99M(+124.5%)
-$83.68M(+65.0%)
Dec 2022
-$238.99M(-415.0%)
-$228.18M(-371.5%)
-$238.99M(-2111.2%)
Sep 2022
-
$84.04M(+1783.5%)
-$10.81M(+88.6%)
Jun 2022
-
$4.46M(+104.5%)
-$94.85M(+4.5%)
Mar 2022
-
-$99.31M(>-9900.0%)
-$99.31M(>-9900.0%)
Dec 2021
-$46.41M(>-9900.0%)
-
-
Jun 2021
-
$0.00(+100.0%)
-$14.00K(0.0%)
Mar 2021
-
-$14.00K
-$14.00K
Dec 2020
-$151.00K(>-9900.0%)
-
-
Dec 2019
$0.00
-
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual cash from investing year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual cash from investing?

The current annual cash from investing of AMLX is $75.65M

What is the all-time high annual cash from investing for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual cash from investing is $92.05M

What is Amylyx Pharmaceuticals, Inc. annual cash from investing year-on-year change?

Over the past year, AMLX annual cash from investing has changed by -$16.40M (-17.81%)

What is Amylyx Pharmaceuticals, Inc. quarterly cash from investing?

The current quarterly cash from investing of AMLX is $22.99M

What is the all-time high quarterly cash from investing for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly cash from investing is $123.22M

What is Amylyx Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?

Over the past year, AMLX quarterly cash from investing has changed by +$51.95M (+179.40%)

What is Amylyx Pharmaceuticals, Inc. TTM cash from investing?

The current TTM cash from investing of AMLX is $83.13M

What is the all-time high TTM cash from investing for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high TTM cash from investing is $92.05M

What is Amylyx Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

Over the past year, AMLX TTM cash from investing has changed by +$198.44M (+172.10%)
On this page